# SkyePharma Production SAS, St Quentin Fallavier, France – FDA Inspections

Source: https://www.keypedia.com/companies/skyepharma-production-sas/e27f2a12-7178-49cb-9ef2-08751d66ffcb

> Inspection records and compliance data for SkyePharma Production SAS in St Quentin Fallavier. 6 FDA inspections on record, last inspected October 27, 2023.

---

## Details

- Name: SkyePharma Production SAS
- FEI Number: 3002808180
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK
- Address Line 1: Zone Industrielle Des Chesnes Ouest, 55 Rue Du Montmurier; Bp 45
- City: St Quentin Fallavier
- Country Name: France
- Address: Zone Industrielle Des Chesnes Ouest, 55 Rue Du Montmurier; Bp 45, St Quentin Fallavier, France
- Country: France

## Related Documents

- FDA Inspection 1265624 - SkyePharma Production SAS - 2023-10-27 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 27, 2023
- FDA Inspection 1205869 - SkyePharma Production SAS - 2023-04-07 — source: FDA, date: April 7, 2023
- FDA Inspection 1105498 - SkyePharma Production SAS - 2019-09-06 — classification: No Action Indicated (NAI), source: FDA, date: September 6, 2019
- FDA Inspection 938881 - SkyePharma Production SAS - 2015-06-19 — classification: No Action Indicated (NAI), source: FDA, date: June 19, 2015
- [FDA Inspection 838912 - SkyePharma Production SAS - 2013-05-31](https://www.keypedia.com/records/fda_inspections/skyepharma-production-sas/cc0dde1d-85bd-495c-9da0-5f946ecac2d6) — classification: No Action Indicated (NAI), source: FDA, date: May 31, 2013
- [FDA Inspection 659061 - SkyePharma Production SAS - 2010-04-02](https://www.keypedia.com/records/fda_inspections/skyepharma-production-sas/c43f2c75-4022-4cfa-bb1e-6fd205981955) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 2, 2010

## Related Companies

- [McNeil AB](https://www.keypedia.com/companies/mcneil-ab/9c06dc92-0eb8-4271-b543-048254a0f580)
- [AndersonBrecon (UK) Limited](https://www.keypedia.com/companies/andersonbrecon-uk-limited/b60e0b8a-fec3-45e5-a4b6-216d0d2f324f)
- [Opella Healthcare International SAS](https://www.keypedia.com/companies/opella-healthcare-international-sas/53ed93ee-b631-49a0-bba2-a57194143394)
- [ANSTO Nuclear Medicine](https://www.keypedia.com/companies/ansto-nuclear-medicine/9bb26b43-b1c1-4d57-9008-7563e01d67e2)
- [Zydus Hospira Oncology Private Ltd.](https://www.keypedia.com/companies/zydus-hospira-oncology-private-ltd/1daf2047-24d1-4343-9500-8a3c69eccaf4)
- [Visum Pharmaceutical Co Ltd](https://www.keypedia.com/companies/visum-pharmaceutical-co-ltd/304efe69-24b4-4b93-aece-f7addcc5e21c)
- [EirGen Pharma Ltd](https://www.keypedia.com/companies/eirgen-pharma-ltd/f9a682ae-b665-4341-814c-af610c74a3ec)
- [Boehringer Ingelheim Espana S.A.](https://www.keypedia.com/companies/boehringer-ingelheim-espana-sa/afd6c8fe-92cc-4db4-8157-94020bcf06d6)
- [R-Pharm Germany GmbH](https://www.keypedia.com/companies/r-pharm-germany-gmbh/00237a65-957b-4892-abce-2844ed37acda)
- [AstraZeneca AB](https://www.keypedia.com/companies/astrazeneca-ab/46419837-c081-4920-b360-9adb4b9bf329)